Uterine Neoplasms Clinical Practice Guidelines in OncologyNCCN Categories of Evidence and ConsensusCategory 1: The recommendation is based on high-level evidence (e.g., randomized controlled trials) and there is uniform NCCN consensus.Category 2A: The recommendation is based on lowerlevel evidence and there is uniform NCCN consensus.Category 2B: The recommendation is based on lowerlevel evidence and there is nonuniform NCCN consensus (but no major disagreement).Category 3: The recommendation is based on any level of evidence but reflects major disagreement.All recommendations are category 2A unless otherwise noted.Clinical trials: The NCCN believes that the best management for any cancer patient is in a clinical trial. Participation in clinical trials is especially encouraged.OverviewAdenocarcinoma of the endometrium is the most common malignancy in the female genital tract in the United States. An estimated 40,100 new diagnoses of uterine cancer and 7470 deaths from this disease will occur in 2008.1 Uterine sarcomas are uncommon and account for approximately 1 in 12 of all uterine cancers.2 These guidelines describe epithelial carcinomas and uterine sarcomas; each of these major categories contains specific histologic groups that require different management (see page 500).By definition, these guidelines cannot incorporate all possible clinical variations and are not intended to replace good clinical judgment or individualization of treatments. Exceptions to the rule were discussed among panel members during the process of developing these guidelines.For patients with suspected uterine neoplasms, initial preoperative evaluation includes a history and physical examination, endometrial biopsy, chest radiograph, a CBC,...

If the inline PDF is not rendering correctly, you can download the PDF file here.

References

  • 1

    JemalASiegelRWardE. Cancer statistics, 2008. CA Cancer J Clin2008;58:7196.

  • 2

    OlahKGeeHBluntS. Retrospective analysis of 318 cases of uterine sarcoma. Eur J Cancer1991;27:10951099.

  • 3

    UedaSMKappDSCheungMK. Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths. Am J Obstet Gynecol2008;198:218.e16.

    • Search Google Scholar
    • Export Citation
  • 4

    DukJMAaldersJGFleurenGJ. CA 125: a useful marker in endometrial carcinoma. Am J Obstet Gynecol1986;155:10971102.

  • 5

    DukJMAaldersJGFleurenGJ. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix. Obstet Gynecol1989;73:661668.

    • Search Google Scholar
    • Export Citation
  • 6

    PatsnerBOrrJWJrMannWJJr. Use of serum CA 125 measurement in posttreatment surveillance of early-stage endometrial carcinoma. Am J Obstet Gynecol1990;162:427429.

    • Search Google Scholar
    • Export Citation
  • 7

    RosePGSommersRMRealeFR. Serial serum CA 125 measurements for evaluation of recurrence in patients with endometrial carcinoma. Obstet Gynecol1994;84:1216.

    • Search Google Scholar
    • Export Citation
  • 8

    PriceFVChambersSKCarcangiuML. CA 125 may not reflect disease status in patients with uterine serous carcinoma. Cancer1998;82:17201725.

    • Search Google Scholar
    • Export Citation
  • 9

    GimpelsonRJRappoldHO. A comparative study between panoramic hysterectomy with directed biopsies and dilatation and curettage: a review of 276 cases. Am J Obstet Gynecol1998;158:489492.

    • Search Google Scholar
    • Export Citation
  • 10

    BoronowRCMorrowCPCreasmanWT. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol1984;63:825832.

    • Search Google Scholar
    • Export Citation
  • 11

    CowlesTAMagrinaJFMastersonBJ. Comparison of clinical and surgical-staging in patients with endometrial carcinoma. Obstet Gynecol1985;66:413416.

    • Search Google Scholar
    • Export Citation
  • 12

    CreasmanWTMorrowCPBundyBN. Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group study. Cancer1987;60:20352041.

    • Search Google Scholar
    • Export Citation
  • 13

    BenedetJLBenderHJonesHIII. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet2000;70:209262.

    • Search Google Scholar
    • Export Citation
  • 14

    American College of Obstetricians and Gynecologists. ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol2005;106:413425.

    • Search Google Scholar
    • Export Citation
  • 15

    MarianiADowdySCClibyWA. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol2008;109:1118.

    • Search Google Scholar
    • Export Citation
  • 16

    ChanJKWuHCheungMK. The outcomes of 27,063 women with unstaged endometrioid uterine cancer. Gynecol Oncol2007;106:282288.

  • 17

    ChanJKKappDS. Role of complete lymphadenectomy in endometrioid uterine cancer. Lancet Oncol2007;8:831841.

  • 18

    ASTEC study groupKitchenerHSwartAM. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet2009;373:125136.

    • Search Google Scholar
    • Export Citation
  • 19

    Benedetti PaniciPBasileSManeschiF. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst2008;100:17071716.

    • Search Google Scholar
    • Export Citation
  • 20

    CreasmanWTOdicinoFMaisonneuveP. Carcinoma of the corpus uteri. FIGO 6th annual report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet2006;95(Suppl 1):S105143.

    • Search Google Scholar
    • Export Citation
  • 21

    FishmanDARobertsKBChambersJT. Radiation therapy as exclusive treatment for medically inoperable patients with stage I and II endometrioid carcinoma of the endometrium. Gynecol Oncol1996;61:189196.

    • Search Google Scholar
    • Export Citation
  • 22

    DanielAGPetersWAIII. Accuracy of office and operating room curettage in the grading of endometrial carcinoma. Gynecol Oncol1988;71:612614.

    • Search Google Scholar
    • Export Citation
  • 23

    GoffBARiceLW. Assessment of depth of myometrial invasion in endometrial adenocarcinoma. Gynecol Oncol1990;38:4648.

  • 24

    KilgoreLCPartridgeEEAlvarezRD. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol1995;56:2933.

    • Search Google Scholar
    • Export Citation
  • 25

    HavrileskyLJCragunJMCalingaertB. Resection of lymph node metastases influences survival in stage IIIC endometrial cancer. Gynecol Oncol2005;99:689695.

    • Search Google Scholar
    • Export Citation
  • 26

    CreutzbergCLvan PuttenWLKoperPC. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet2000;355:14041411.

    • Search Google Scholar
    • Export Citation
  • 27

    AaldersJAbelerVKolstadP. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma. Clinical and histopathologic study of 540 patients. Obstet Gynecol1980;56:419427.

    • Search Google Scholar
    • Export Citation
  • 28

    KeysHMRobertsJABrunettoVL. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol2004;92:744751.

    • Search Google Scholar
    • Export Citation
  • 29

    CreutzbergCLvan PuttenWLWarlam-RodenhuisCC. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial. J Clin Oncol2004;22:12341241.

    • Search Google Scholar
    • Export Citation
  • 30

    ScholtenANvan PuttenWLBeermanH. Postoperative radiotherapy for stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review. Int J Radiat Oncol Biol Phys2005;63:834838.

    • Search Google Scholar
    • Export Citation
  • 31

    AlektiarKMVenkatramanEChiDSBarakatRR. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer. Int J Radiat Oncol Biol Phys2005;62:111117.

    • Search Google Scholar
    • Export Citation
  • 32

    NoutRAPutterHJürgenliemk-SchulzIM. Vaginal brachytherapy versus external beam pelvic radiotherapy for high-intermediate risk endometrial cancer: results of the randomized PORTEC-2 trial [abstract]. J Clin Oncol2008;26:Abstract LBA5503.

    • Search Google Scholar
    • Export Citation
  • 33

    ASTEC/EN.5 Study GroupBlakePSwartAM. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet2009;373:137146.

    • Search Google Scholar
    • Export Citation
  • 34

    LeeCMSzaboAShrieveDC. Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma. JAMA2006;295:389397.

    • Search Google Scholar
    • Export Citation
  • 35

    JohnsonNCornesP. Survival and recurrent disease after postoperative radiotherapy for early endometrial cancer: systematic review and meta-analysis. BJOG2007;114:13131320.

    • Search Google Scholar
    • Export Citation
  • 36

    KongAJohnsonNCornesP. Adjuvant radiotherapy for stage I endometrial cancer. Cochrane Database Syst Rev2007;CD003916.

  • 37

    KohWJTranABDouglasJG. Radiation therapy in endometrial cancer. Best Pract Res Clin Obstet Gynaecol2001;15:417432.

  • 38

    HogbergTRosenbergPKristensenG. A randomized phase-III study on adjuvant treatment with radiation (RT) ± chemotherapy (CT) in early-stage high-risk endometrial cancer (NSGO-EC-9501/EORTC 55991) [abstract]. J Clin Oncol2007;25:Abstract 5503.

    • Search Google Scholar
    • Export Citation
  • 39

    MorrowCPBundyBNKurmanRJ. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol1991;40:5565.

    • Search Google Scholar
    • Export Citation
  • 40

    KadarNHomesleyHDMalfetanoJH. Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease. Gynecol Oncol1992;46:145149.

    • Search Google Scholar
    • Export Citation
  • 41

    Owen Mumford. Best Practice Guidelines on the Use of Vaginal Dilators in Women Receiving Pelvic radiotherapy. Available at: http://www.owenmumford.com/en/download.asp?id=59. Accessed March 25 2009.

    • Search Google Scholar
    • Export Citation
  • 42

    WalkerJLPiedmonteMSpirtosN. Surgical staging of uterine cancer: randomized phase III trial of laparoscopy vs laparotomy—a Gynecologic Oncology Group study (GOG): preliminary results [Abstract]. J Clin Oncol2006;24(Suppl 18):Abstract 5010.

    • Search Google Scholar
    • Export Citation
  • 43

    MalurSPossoverMMichelsWSchneiderA. Laparoscopic-assisted vaginal versus abdominal surgery in patients with endometrial cancer—a prospective randomized trial. Gynecol Oncol2001;80:239244.

    • Search Google Scholar
    • Export Citation
  • 44

    ObermairAManolitsasTPLeungY. Total laparoscopic hysterectomy for endometrial cancer: patterns of recurrence and survival. Gynecol Oncol2004;92:789793.

    • Search Google Scholar
    • Export Citation
  • 45

    BoggessJFGehrigPACantrellL. A comparative study of 3 surgical methods for hysterectomy with staging for endometrial cancer: robotic assistance, laparoscopy, laparotomy. Am J Obstet Gynecol2008;199:360.e19.

    • Search Google Scholar
    • Export Citation
  • 46

    BanderaCAMagrinaJF. Robotic surgery in gynecologic oncology. Curr Opin Obstet Gynecol2009;21:2530.

  • 47

    ChadhaMNanavatiPJLiuP. Patterns of failure in endometrial carcinoma stage IB, grade 3 and IC patients treated with postoperative vaginal vault brachytherapy. Gynecol Oncol1999;75:103107.

    • Search Google Scholar
    • Export Citation
  • 48

    KongAPowellMBlakeP. The role of postoperative radiotherapy in carcinoma of the endometrium. Clin Oncol (R Coll Radiol)2008;20:457462.

    • Search Google Scholar
    • Export Citation
  • 49

    SolhjemMCPetersenIAHaddockMG. Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endometrial cancer. Int J Radiat Oncol Biol Phys2005;62:13791384.

    • Search Google Scholar
    • Export Citation
  • 50

    ChiDSBarakatRRPalayekarMJ. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. Int J Gynecol Cancer2008;18:269273.

    • Search Google Scholar
    • Export Citation
  • 51

    GretzHFIIIEconomosKHusainA. The practice of surgical staging and its impact on adjuvant treatment recommendations in patients with stage I endometrial carcinoma. Gynecol Oncol1996;61:409415.

    • Search Google Scholar
    • Export Citation
  • 52

    Ben-ShacharIPavelkaJCohnDE. Surgical staging for patients presenting with grade 1 endometrial carcinoma. Obstet Gynecol2005;105:487493.

    • Search Google Scholar
    • Export Citation
  • 53

    GrevenKMLancianoRMCornB. Pathologic stage III endometrial carcinoma-prognostic factors and patterns of recurrence. Cancer1993;71:36973702.

    • Search Google Scholar
    • Export Citation
  • 54

    SusumuNSagaeSUdagawaY. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecol Oncol2008;108:226233.

    • Search Google Scholar
    • Export Citation
  • 55

    HogbergT. Adjuvant chemotherapy in endometrial carcinoma: overview of randomised trials. Clin Oncol (R Coll Radiol)2008;20:463469.

  • 56

    FlemingG. Adjuvant therapy for high-risk adenocarcinoma of the uterus. ASCO Educational Book2008:230233.

  • 57

    GibbonsSMartinezASchrayM. Adjuvant whole abdominopelvic irradiation for high-risk endometrial carcinoma. Int J Radiat Oncol Biol Phys1991;21:10191025.

    • Search Google Scholar
    • Export Citation
  • 58

    GreerBEHambergerAD. Treatment of intraperitoneal metastatic adenocarcinoma of the endometrium by the whole-abdomen moving-strip technique and pelvic boost irradiation. Gynecol Oncol1983;16:365373.

    • Search Google Scholar
    • Export Citation
  • 59

    RandallMEFiliaciVLMussH. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol2006;24:3644.

    • Search Google Scholar
    • Export Citation
  • 60

    HomesleyHDFiliaciVGibbonsSK. Randomized phase III trial in advanced endometrial carcinoma of surgery and volume-directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: a Gynecologic Oncology Group study [abstract]. 39th Annual Meeting of the Society of Gynecologic Oncologists; Tampa, FL; March 9, 2008. Abstract #1. Gynecol Oncol2008;108:S2.

    • Search Google Scholar
    • Export Citation
  • 61

    SmithDCPrenticeRThompsonDJ. Association of exogenous estrogen and endometrial cancer. N Engl J Med1975;293:11641167.

  • 62

    ZielHKFinkleWD. Increased incidence of endometrial carcinoma among users of conjugated estrogens. N Engl J Med1975;293:11671170.

  • 63

    CreasmanWTHendersonDHinshawW. Estrogen replacement therapy in the patient treated for endometrial cancer. Obstet Gynecol1986;67:326330.

    • Search Google Scholar
    • Export Citation
  • 64

    LeeRBBurkeTWParkeRC. Estrogen replacement therapy following treatment for stage I endometrial carcinoma. Gynecol Oncol1990;36:189191.

    • Search Google Scholar
    • Export Citation
  • 65

    ChapmanJADiSaiaPJOsannK. Estrogen replacement in surgical stage I and II endometrial cancer survivors. Am J Obstet Gynecol1996;175:11951200.

    • Search Google Scholar
    • Export Citation
  • 66

    GotliebWHBeinerMEShalmonB. Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer. Obstet Gynecol2003;102:718725.

    • Search Google Scholar
    • Export Citation
  • 67

    RamirezPTFrumovitzMBodurkaDC. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol2004;95:133138.

    • Search Google Scholar
    • Export Citation
  • 68

    PodczaskiEKaminskiPGurskiK. Detection and patterns of treatment failure in 300 consecutive cases of “early” endometrial cancer after primary surgery. Gynecol Oncol1992;47:323327.

    • Search Google Scholar
    • Export Citation
  • 69

    ShumskyAGStuartGCBrasherPM. An evaluation of routine follow-up of patients treated for endometrial carcinoma. Gynecol Oncol1994;55:229233.

    • Search Google Scholar
    • Export Citation
  • 70

    BerchuckAAnspachCEvansAC. Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma. Gynecol Oncol1995;59:2022.

    • Search Google Scholar
    • Export Citation
  • 71

    ReddochJMBurkeTWMorrisM. Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme. Gynecol Oncol1995;59:221225.

    • Search Google Scholar
    • Export Citation
  • 72

    GreerBEGoffBAKohWJ. Endometrial carcinoma. In: JohnsonFEVirgoKS eds. Cancer Patient Follow-up. St. Louis: Mosby; 1997:357377.

  • 73

    BarakatRRGoldmanNAPatelDA. Pelvic exenteration for recurrent endometrial cancer. Gynecol Oncol1999;75:99102.

  • 74

    DowdySCMarianiAClibyWA. Radical pelvic resection and intraoperative radiation therapy for recurrent endometrial cancer: technique and analysis of outcomes. Gynecol Oncol2006;101:280286.

    • Search Google Scholar
    • Export Citation
  • 75

    TranPTSuZHaraW. Long-term survivors using intraoperative radiotherapy for recurrent gynecologic malignancies. Int J Radiat Oncol Biol Phys2007;69:504511.

    • Search Google Scholar
    • Export Citation
  • 76

    PoulsenMGRobertsSJ. The salvage of recurrent endometrial carcinoma in the vagina and pelvis. Int J Radiat Oncol Biol Phys1988;15:809813.

    • Search Google Scholar
    • Export Citation
  • 77

    KauppilaA. Oestrogen and progestin receptors as prognostic indicators in endometrial cancer. A review of the literature. Acta Oncol1989;28:561566.

    • Search Google Scholar
    • Export Citation
  • 78

    ThigpenJTBradyMFAlvarezRD. Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group. J Clin Oncol1999;17:17361744.

    • Search Google Scholar
    • Export Citation
  • 79

    QuinnMACampbellJJ. Tamoxifen therapy in advanced/recurrent endometrial carcinoma. Gynecol Oncol1989;32:13.

  • 80

    ThigpenTBradyMFHomesleyHD. Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol2001;19:364367.

    • Search Google Scholar
    • Export Citation
  • 81

    BurkeTWWalkerCL. Arzoxifene as therapy for endometrial cancer. Gynecol Oncol2003;90(2 Pt 2):S4046.

  • 82

    QuinnMA. Hormonal treatment of endometrial cancer. Hematol Oncol Clin North Am1999;13:163187.

  • 83

    FlemingGFBrunettoVLCellaD. Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol2004;22:21592166.

    • Search Google Scholar
    • Export Citation
  • 84

    MussHB. Chemotherapy of metastatic endometrial cancer. Semin Oncol1994;21:107113.

  • 85

    ReddySPKudelkaAPGonzalez de LeonC. Tumors of the uterine corpus. In: PazdurR ed. Medical Oncology: A Comprehensive Review. Huntington: PRR; 1996:407416.

    • Search Google Scholar
    • Export Citation
  • 86

    SovakMADupontJHensleyML. Paclitaxel and carboplatin in the treatment of advanced or recurrent endometrial cancer: a large retrospective study. Int J Gynecol Cancer2007;17:197203.

    • Search Google Scholar
    • Export Citation
  • 87

    SecordAAHavrileskyLJCarneyME. Weekly low-dose paclitaxel and carboplatin in the treatment of advanced or recurrent cervical and endometrial cancer. Int J Clin Oncol2007;12:3136.

    • Search Google Scholar
    • Export Citation
  • 88

    GoffBAKatoDSchmidtRA. Uterine papillary serous carcinoma: patterns of metastatic spread. Gynecol Oncol199453:264268.

  • 89

    HendricksonMRLongacreTAKempsonRL. Uterine papillary serous carcinoma revisited. Gynecol Oncol1994;54:261263.

  • 90

    McCluggageWG. Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas. Int J Gynecol Cancer2002;12:687690.

    • Search Google Scholar
    • Export Citation
  • 91

    KellyMGO’MalleyDMHuiP. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. Gynecol Oncol2005;98:353359.

    • Search Google Scholar
    • Export Citation
  • 92

    ThomasMBMarianiAClibyWA. Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma. Gynecol Oncol2007;107:186189.

    • Search Google Scholar
    • Export Citation
  • 93

    GoldbergHMillerRCAbdah-BortnyakR. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN). Gynecol Oncol2008;108:298305.

    • Search Google Scholar
    • Export Citation
  • 94

    HamiltonCACheungMKOsannK. The effect of adjuvant chemotherapy versus whole abdominopelvic radiation on the survival of patients with advanced stage uterine papillary serous carcinoma. Gynecol Oncol2006;103:679683.

    • Search Google Scholar
    • Export Citation
  • 95

    GriceJEkMGreerBE. Uterine papillary serous carcinoma (UPSC): evaluation of long-term survival in 36 surgically staged patients. Gynecol Oncol1998;69:6973.

    • Search Google Scholar
    • Export Citation
  • 96

    HavrileskyLJSecordAABae-JumpV. Outcomes in surgical stage I uterine papillary serous carcinoma. Gynecol Oncol2007;105:677682.

  • 97

    MehtaNYamadaSDRotmenschJMundtAJ. Outcome and pattern of failure in pathologic stage I-II papillary serous carcinoma of the endometrium: implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys2003;57:10041009.

    • Search Google Scholar
    • Export Citation
  • 98

    MurphyKTRotmenschJYamadaSDMundtAJ. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys2003;55:12721276.

    • Search Google Scholar
    • Export Citation
  • 99

    SoodBMJonesJGuptaS. Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma. Int J Radiat Oncol Biol Phys2003;57:208216.

    • Search Google Scholar
    • Export Citation
  • 100

    WolfsonAHBradyMFRoceretoT. A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus. Gynecol Oncol2007;107:177185.

    • Search Google Scholar
    • Export Citation
  • 101

    HomesleyHDFiliaciVMarkmanM. Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group study. J Clin Oncol2007;25:526531.

    • Search Google Scholar
    • Export Citation
  • 102

    SuttonGKaudererJCarsonLF. Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study. Gynecol Oncol2005;96:630634.

    • Search Google Scholar
    • Export Citation
  • 103

    ReedNSMangioniCMalmströmH. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group study (protocol 55874). Eur J Cancer2008;44:808818.

    • Search Google Scholar
    • Export Citation
  • 104

    CallisterMRamondettaLMJhingranA. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome. Int J Radiat Oncol Biol Phys2004;58:786796.

    • Search Google Scholar
    • Export Citation
  • 105

    ChiDMychalczakBSaigoP. The role of whole-pelvic irradiation in the treatment of early-stage uterine carcinosarcoma. Gynecol Oncol1997;65:493498.

    • Search Google Scholar
    • Export Citation
  • 106

    KnockeTWeitmannHKuceraH. Results of primary and adjuvant radiotherapy in the treatment of mixed Mullerian tumors of the corpus uteri. Gynecol Oncol1999;73:389395.

    • Search Google Scholar
    • Export Citation
  • 107

    LarsonBSilfverswardCNilssonB. Mixed mullerian tumours of the uterus—prognostic factors: a clinical and histopathologic study of 147 cases. Radiother Oncol1990;17:123132.

    • Search Google Scholar
    • Export Citation
  • 108

    GersztenKFaulCKounelisS. The impact of adjuvant radiotherapy on carcinosarcoma of the uterus. Gynecol Oncol1998;68:813.

  • 109

    DusenberyKEPotishRAArgentaPAJudsonPL. On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterus. Am J Clin Oncol2005;28:295300.

    • Search Google Scholar
    • Export Citation
  • 110

    NemaniDMitraNGuoMLinL. Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis. Gynecol Oncol2008;111:8288.

    • Search Google Scholar
    • Export Citation
  • 111

    WolfsonAHBradyMFRoceretoT. A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus. Gynecol Oncol2007;107:177185.

    • Search Google Scholar
    • Export Citation
  • 112

    PinkDLindnerTMrozekA. Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature. Gynecol Oncol2006;101:464469.

    • Search Google Scholar
    • Export Citation
  • 113

    MansiJRamachandraSWiltshawE. Endometrial stromal sarcomas. Gynecol Oncol1990;36:113118.

  • 114

    BerchuckARubinSHoskinsW. Treatment of endometrial stromal tumors. Gynecol Oncol1990;36:6065.

  • 115

    WeitmannHKnockeTKuceraH. Radiation therapy in the treatment of endometrial stromal sarcoma. Int J Radiat Oncol Biol Phys2001;49:739748.

    • Search Google Scholar
    • Export Citation
  • 116

    BrennerDJHallEJ. Computed tomography—an increasing source of radiation exposure. N Engl J Med2007;357:22772284.

  • 117

    ZivanovicOIasonosALeitaoMM. Stage-specific survival of patients with uterine leiomyosarcoma: a comparison of FIGO and AJCC staging system [abstract]. J Clin Oncol2008;26:Abstract 5554.

    • Search Google Scholar
    • Export Citation
  • 118

    GiuntoliRNMetzingerDDiMarcoC. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol2003;89:460469.

    • Search Google Scholar
    • Export Citation
  • 119

    DusenberyKEPotishRAJudsonP. Limitations of adjuvant radiotherapy for uterine sarcomas spread beyond the uterus. Gynecol Oncol2004;94:191196.

    • Search Google Scholar
    • Export Citation
  • 120

    Sarcoma Meta-analysis Collaboration (SMAC). Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults. Cochrane Database Syst Rev2000;CD001419.

    • Search Google Scholar
    • Export Citation
  • 121

    HensleyMLMakiRVenkatramanE. Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol2002;20:28242831.

    • Search Google Scholar
    • Export Citation
  • 122

    HensleyMLBlessingJAMannelRRosePG. Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial. Gynecol Oncol2008;109:329334.

    • Search Google Scholar
    • Export Citation
  • 123

    LookKYSandlerABlessingJA. Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) study. Gynecol Oncol2004;92:644647.

    • Search Google Scholar
    • Export Citation
  • 124

    JudsonIRadfordJAHarrisM. Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer2001;37:870877.

    • Search Google Scholar
    • Export Citation
  • 125

    SuttonGBlessingJHanjaniP. Phase II evaluation of liposomal doxorubicin (Doxil) in recurrent or advanced leiomyosarcoma of the uterus: a Gynecologic Oncology Group study. Gynecol Oncol2005;96:749752.

    • Search Google Scholar
    • Export Citation
  • 126

    GallupDGBlessingJAAndersenW. Evaluation of paclitaxel in previously treated leiomyosarcoma of the uterus: a gynecologic oncology group study. Gynecol Oncol2003;89:4851.

    • Search Google Scholar
    • Export Citation

Article Information

PubMed

Google Scholar

Related Articles

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 205 205 46
PDF Downloads 73 73 16
EPUB Downloads 0 0 0